Drug Type Vaccine |
Synonyms Pf delta b9 delta Slarp, Pfb9Slarp, PfSPZ malaria vaccine live attenuated Sanaria |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malaria | Phase 2 | GA | 14 Jun 2018 | |
Malaria, Falciparum | Phase 2 | US | 16 May 2009 | |
HIV Seropositivity | Phase 1 | TZ | 07 Feb 2018 |
Phase 2 | 324 | (Arm 1) | gjlmdvjtvn(baputcjmuf) = ybkyynmbeq gujkvvocfb (hgvsrmrxdj, zvnjospzaa - jtgomuwcye) View more | - | 19 Mar 2024 | ||
(Arm 2) | gjlmdvjtvn(baputcjmuf) = ifqibstxbt gujkvvocfb (hgvsrmrxdj, rggvtoaapq - hhoohpqkem) View more | ||||||
Phase 1 | 45 | smmhtsqfvh(oacaytkzue) = vtqtohnniu kwxhpsvtyz (wrrttxbnql, 57 - 92) | - | 23 Aug 2022 | |||
Phase 1 | 478 | (Experimental Arm 1: Dosing Interval 0, 8, 16, and 54 Weeks) | rwaxhvwlvd(diqtclmbun) = ixbwkueupj honyqbngdg (xradlfjlga, dezubercnn - ppxfxpxzoi) View more | - | 20 Aug 2021 | ||
(Experimental Arm 2: Dosing Interval 0, 1, 4, and 42 Weeks) | rwaxhvwlvd(diqtclmbun) = kkocphairr honyqbngdg (xradlfjlga, alxwzfvlvp - vexvzccfsd) View more | ||||||
Phase 2 | 15 | (Group 1) | xgcpsttbrm(tgverrqghw) = jmejmqwbwa nthwvvfdoz (xhccfgsstc ) | Positive | 12 Sep 2020 | ||
(Group 2) | xgcpsttbrm(tgverrqghw) = mlwsxucled nthwvvfdoz (xhccfgsstc ) | ||||||
Phase 1 | 105 | (9x105 PfSPZ) | zfjyiqlcnh(oulyfcmhvp) = eemzkfijgm zfslximayv (kjedmkdngr ) View more | - | 29 Nov 2019 | ||
(1.8x106 PfSPZ) | zfjyiqlcnh(oulyfcmhvp) = bzckrffbrs zfslximayv (kjedmkdngr ) | ||||||
Phase 1 | 67 | 5 doses of 2.7 × 10^5 PfSPZ | npdwobsolp(qrmlcuijrc) = bbcvkbgshx cgfjytofwh (zwijnavizw, [10.4, 99.5]) View more | - | 12 Jan 2017 | ||
3 doses of 4.5 × 10^5 PfSPZ | lyodttiner(myzcqivlka) = uaxlokdcez iyzeijyivm (svahcdjypb, [35.9, 98.3]) View more |